Multiple Assemblies exist for SMTL entry 6n3l
Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents; X-RAY DIFFRACTION 2.61 Å

	SMTL ID 6n3l.1 Ligands N-{6-[(1-methyl-2-{[4-(trifluoromethyl)phenyl]amino}-1H-benzimidazol-5-yl)oxy]pyrimidin-4-yl}cyclopropanecarboxamide Polypeptides eIF-2-alpha kinase GCN2,eIF-2-alpha kinase GCN2 Oligo-state monomer
	SMTL ID 6n3l.2 Ligands N-{6-[(1-methyl-2-{[4-(trifluoromethyl)phenyl]amino}-1H-benzimidazol-5-yl)oxy]pyrimidin-4-yl}cyclopropanecarboxamide Polypeptides eIF-2-alpha kinase GCN2,eIF-2-alpha kinase GCN2 Oligo-state monomer